Alector Therapeutics, working with AbbVie, was testing whether modulating immune cells in brain would slow Alzheimer's ...

The Cassava Sciences story ended Monday exactly as many knew it would — with the company’s experimental drug for Alzheimer’s ...

Late Friday evening, President-elect Donald Trump announced a slew of intended nominations for his administration, including ...

Minnesota has becomes the first state to release a report examining the 340B drug discount program for "safety-net" hospitals ...

Join clinical experts as they address treatment challenges for breast cancer patients & explore the latest advancements at ...

First-of-its-kind data analysis finds UnitedHealth Group pays many of its own physician practices significantly more than the ...

The presumptive new CDC director, Dave Weldon, is a known vaccine safety skeptic. In contrast, the FDA choice — Johns Hopkins ...

Opinion: RFK Jr. should look to what his uncle might have done: a large-scale public health program meeting people where they ...

The U.S. life sciences community is bracing for the return of travel restrictions in the second Trump administration.